Nifty
Sensex
:
:
17853.20
60048.47
30.25 (0.17%)
163.11 (0.27%)

Chemicals

Rating :
80/99

BSE: 530999 | NSE: BALAMINES

4616.00
24-Sep-2021
  • Open
  • High
  • Low
  • Previous Close
  •  4697.35
  •  4697.35
  •  4550.00
  •  4673.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  46866
  •  2159.08
  •  5223.55
  •  775.70

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 14,951.44
  • 50.58
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 15,058.86
  • 0.09%
  • 15.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.67%
  • 1.00%
  • 39.47%
  • FII
  • DII
  • Others
  • 2.35%
  • 0.02%
  • 3.49%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.30
  • 14.36
  • 11.62

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.59
  • 19.80
  • 13.95

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.92
  • 23.67
  • 26.55

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.01
  • 16.84
  • 13.25

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.40
  • 4.51
  • 4.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.41
  • 11.66
  • 12.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
450.68
222.91
102.18%
414.03
258.03
60.46%
392.13
227.52
72.35%
282.38
227.25
24.26%
Expenses
307.65
169.68
81.31%
285.11
202.40
40.86%
274.76
184.68
48.78%
208.68
182.49
14.35%
EBITDA
143.03
53.23
168.70%
128.92
55.63
131.75%
117.37
42.84
173.97%
73.70
44.77
64.62%
EBIDTM
31.74%
23.88%
31.14%
21.56%
29.93%
18.83%
26.10%
19.70%
Other Income
1.26
1.28
-1.56%
3.60
1.56
130.77%
0.51
0.59
-13.56%
0.69
1.46
-52.74%
Interest
3.14
4.32
-27.31%
3.78
6.30
-40.00%
4.81
6.31
-23.77%
5.38
7.17
-24.97%
Depreciation
9.68
7.93
22.07%
8.47
10.12
-16.30%
8.71
7.96
9.42%
9.30
7.82
18.93%
PBT
131.48
42.25
211.20%
120.27
40.77
195.00%
104.36
29.15
258.01%
59.71
31.23
91.19%
Tax
34.09
10.67
219.49%
31.46
11.21
180.64%
25.45
8.46
200.83%
15.51
2.49
522.89%
PAT
97.40
31.58
208.42%
88.81
29.56
200.44%
78.90
20.69
281.34%
44.20
28.74
53.79%
PATM
21.61%
14.17%
21.45%
11.46%
20.12%
9.09%
15.65%
12.65%
EPS
27.90
10.17
174.34%
26.08
9.51
174.24%
23.14
7.22
220.50%
14.12
9.70
45.57%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
1,539.22
1,311.46
935.77
943.05
861.23
670.48
643.15
618.77
610.13
511.80
449.52
Net Sales Growth
64.50%
40.15%
-0.77%
9.50%
28.45%
4.25%
3.94%
1.42%
19.21%
13.85%
 
Cost Of Goods Sold
731.57
630.25
513.83
515.35
464.09
342.37
356.22
359.55
380.97
312.20
262.65
Gross Profit
807.65
681.20
421.94
427.69
397.15
328.12
286.92
259.23
229.15
199.59
186.87
GP Margin
52.47%
51.94%
45.09%
45.35%
46.11%
48.94%
44.61%
41.89%
37.56%
39.00%
41.57%
Total Expenditure
1,076.20
943.52
758.29
751.50
679.20
521.40
519.86
517.02
522.77
432.46
370.23
Power & Fuel Cost
-
125.02
95.03
84.70
76.52
57.94
62.42
64.58
63.81
54.34
49.99
% Of Sales
-
9.53%
10.16%
8.98%
8.88%
8.64%
9.71%
10.44%
10.46%
10.62%
11.12%
Employee Cost
-
33.56
34.07
29.47
26.89
24.47
21.63
20.90
15.84
12.90
11.90
% Of Sales
-
2.56%
3.64%
3.12%
3.12%
3.65%
3.36%
3.38%
2.60%
2.52%
2.65%
Manufacturing Exp.
-
18.13
15.05
19.26
16.04
18.96
10.33
27.10
24.72
22.35
19.01
% Of Sales
-
1.38%
1.61%
2.04%
1.86%
2.83%
1.61%
4.38%
4.05%
4.37%
4.23%
General & Admin Exp.
-
48.36
28.82
30.08
29.26
26.93
41.13
16.55
12.92
11.03
10.34
% Of Sales
-
3.69%
3.08%
3.19%
3.40%
4.02%
6.40%
2.67%
2.12%
2.16%
2.30%
Selling & Distn. Exp.
-
84.33
68.69
70.01
64.51
49.38
27.10
26.28
24.49
19.62
16.35
% Of Sales
-
6.43%
7.34%
7.42%
7.49%
7.36%
4.21%
4.25%
4.01%
3.83%
3.64%
Miscellaneous Exp.
-
3.85
2.79
2.63
1.89
1.35
1.03
2.06
0.02
0.00
16.35
% Of Sales
-
0.29%
0.30%
0.28%
0.22%
0.20%
0.16%
0.33%
0.00%
0%
0%
EBITDA
463.02
367.94
177.48
191.55
182.03
149.08
123.29
101.75
87.36
79.34
79.29
EBITDA Margin
30.08%
28.06%
18.97%
20.31%
21.14%
22.23%
19.17%
16.44%
14.32%
15.50%
17.64%
Other Income
6.06
11.36
8.28
6.08
11.53
8.54
6.21
4.26
6.27
4.60
4.22
Interest
17.11
18.29
23.03
13.03
9.04
12.94
22.15
34.88
31.51
25.40
21.21
Depreciation
36.16
34.41
31.62
19.55
19.29
19.71
19.38
20.08
16.49
12.71
10.38
PBT
415.82
326.60
131.10
165.06
165.24
124.98
87.96
51.07
45.63
45.82
51.93
Tax
106.51
83.10
33.63
47.97
52.66
43.34
30.35
17.87
12.12
14.77
17.08
Tax Rate
25.61%
25.44%
25.65%
29.06%
31.75%
34.48%
34.50%
34.99%
26.56%
32.15%
32.40%
PAT
309.31
238.20
104.80
117.53
113.18
82.35
57.61
34.27
33.51
31.17
35.64
PAT before Minority Interest
295.62
243.50
97.47
117.09
113.18
82.35
57.61
33.20
33.51
31.17
35.64
Minority Interest
-13.69
-5.30
7.33
0.44
0.00
0.00
0.00
1.07
0.00
0.00
0.00
PAT Margin
20.10%
18.16%
11.20%
12.46%
13.14%
12.28%
8.96%
5.54%
5.49%
6.09%
7.93%
PAT Growth
179.74%
127.29%
-10.83%
3.84%
37.44%
42.94%
68.11%
2.27%
7.51%
-12.54%
 
EPS
95.47
73.52
32.35
36.27
34.93
25.42
17.78
10.58
10.34
9.62
11.00

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
894.39
658.14
574.46
467.06
362.46
280.21
227.91
201.12
171.38
145.11
Share Capital
6.48
6.48
6.48
6.48
6.48
6.48
6.48
6.48
6.48
6.48
Total Reserves
887.91
651.66
567.98
460.58
355.98
273.73
221.43
194.64
164.90
138.63
Non-Current Liabilities
157.60
180.39
145.45
106.05
73.46
108.91
136.28
136.40
149.40
126.44
Secured Loans
84.85
115.91
83.33
40.68
15.01
35.95
65.98
83.37
103.72
86.15
Unsecured Loans
4.00
4.00
0.00
1.81
1.81
10.44
8.82
5.56
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
242.81
264.34
308.43
256.73
199.09
215.62
256.37
282.71
198.57
194.11
Trade Payables
76.80
59.36
85.05
71.84
51.47
48.47
47.55
86.35
35.51
34.71
Other Current Liabilities
33.69
22.45
37.55
9.95
22.14
33.18
42.40
42.67
36.34
25.79
Short Term Borrowings
10.95
121.48
107.41
99.68
66.21
101.17
148.46
139.46
105.58
111.05
Short Term Provisions
121.37
61.06
78.42
75.25
59.27
32.80
17.96
14.23
21.14
22.56
Total Liabilities
1,310.33
1,113.10
1,045.90
847.84
635.01
604.74
622.55
620.23
519.35
465.66
Net Block
542.92
573.00
319.75
316.06
325.48
340.82
341.11
325.39
234.38
196.00
Gross Block
789.57
786.40
501.88
479.10
461.74
468.91
448.42
415.85
303.99
253.23
Accumulated Depreciation
246.66
213.40
182.14
163.04
136.26
128.10
107.32
90.46
69.61
57.23
Non Current Assets
732.92
652.06
595.95
492.58
355.45
359.41
346.75
335.79
299.37
225.72
Capital Work in Progress
173.28
46.27
269.46
123.13
25.08
16.26
3.32
8.12
62.92
24.67
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.02
0.02
0.02
0.02
4.01
Long Term Loans & Adv.
15.75
31.84
5.78
46.32
4.89
2.32
2.11
2.05
1.80
1.05
Other Non Current Assets
0.98
0.95
0.96
7.08
0.00
0.00
0.20
0.23
0.26
0.00
Current Assets
577.08
460.61
449.40
354.72
279.56
245.33
275.80
284.44
219.97
239.94
Current Investments
0.00
47.50
0.00
0.01
0.02
0.00
0.00
19.94
19.94
3.84
Inventories
109.94
108.81
163.15
89.10
98.98
78.03
112.38
90.64
56.75
107.40
Sundry Debtors
305.66
207.44
167.22
172.68
124.29
124.34
119.37
131.53
103.71
82.14
Cash & Bank
19.64
8.81
20.40
24.16
3.49
8.57
7.00
9.75
2.68
4.48
Other Current Assets
141.85
3.80
2.73
2.56
52.78
34.39
37.06
32.60
36.89
42.08
Short Term Loans & Adv.
134.81
84.26
95.91
66.22
51.82
33.40
35.74
30.96
36.89
42.08
Net Current Assets
334.28
196.27
140.98
97.99
80.47
29.71
19.42
1.73
21.40
45.83
Total Assets
1,310.33
1,113.11
1,045.89
847.84
635.01
604.74
622.55
620.23
519.34
465.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
109.87
144.20
94.21
139.98
60.46
84.78
55.76
110.64
94.40
52.97
PBT
344.89
154.14
178.08
174.88
138.53
110.11
85.94
77.14
71.34
73.93
Adjustment
28.34
26.61
15.33
15.21
14.75
16.61
15.82
13.89
9.02
6.82
Changes in Working Capital
-225.12
15.11
-49.48
-7.11
-66.51
-28.81
-35.97
31.86
28.47
-18.68
Cash after chg. in Working capital
148.11
195.85
143.93
182.98
86.78
97.91
65.79
122.89
108.83
62.06
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-38.24
-51.65
-49.71
-43.00
-26.32
-13.13
-10.03
-12.24
-14.43
-9.09
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-61.59
-130.12
-118.69
-134.87
-10.32
-29.26
-3.76
-50.08
-85.79
-56.37
Net Fixed Assets
-130.14
-51.89
-18.14
-75.70
-12.82
-32.02
-7.91
-52.32
-89.02
-58.89
Net Investments
47.50
-47.50
0.01
-35.86
0.00
0.00
-9.50
0.00
-12.10
0.00
Others
21.05
-30.73
-100.56
-23.31
2.50
2.76
13.65
2.24
15.33
2.52
Cash from Financing Activity
-37.45
-25.67
20.71
15.56
-55.21
-53.95
-55.07
-53.49
-10.42
-1.16
Net Cash Inflow / Outflow
10.83
-11.59
-3.77
20.67
-5.08
1.57
-3.07
7.07
-1.80
-4.55
Opening Cash & Equivalents
8.81
20.40
24.16
3.49
8.57
7.00
10.07
2.68
4.48
9.03
Closing Cash & Equivalent
19.64
8.81
20.40
24.16
3.49
8.57
7.00
9.74
2.68
4.48

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
275.94
202.99
177.13
143.99
111.87
86.48
70.34
62.07
52.89
44.78
ROA
20.10%
9.03%
12.37%
15.27%
13.29%
9.39%
5.34%
5.88%
6.33%
8.58%
ROE
31.38%
15.83%
22.51%
27.31%
25.63%
22.68%
15.48%
17.99%
19.70%
27.67%
ROCE
35.58%
17.94%
25.09%
32.21%
30.13%
23.51%
18.16%
17.65%
18.47%
23.80%
Fixed Asset Turnover
1.66
1.45
1.92
1.86
1.57
1.52
1.56
1.85
2.00
2.11
Receivable days
71.40
73.07
65.78
61.97
62.11
63.70
67.97
64.32
60.97
58.54
Inventory Days
30.44
53.04
48.82
39.25
44.22
49.77
54.99
40.30
53.85
66.85
Payable days
25.71
34.25
36.81
33.88
34.15
35.87
46.70
40.28
30.76
31.60
Cash Conversion Cycle
76.14
91.85
77.78
67.33
72.18
77.61
76.26
64.35
84.06
93.79
Total Debt/Equity
0.14
0.39
0.40
0.33
0.29
0.62
1.12
1.30
1.40
1.49
Interest Cover
18.85
6.69
13.67
19.34
10.72
4.97
2.46
2.45
2.81
3.49

News Update:


  • Balaji Amines gets nod to set up new plant for manufacturing Acetonitrile
    4th Aug 2021, 10:52 AM

    The Board of Directors of the company at their Meeting held on August 02, 2021 has approved the same

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.